中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
Author:(Judith WENDLER)

1.Ustekinumab is effective in biological refractory Crohn's disease patients–regardless of approval study selection criteria

Sadik SAMAN ; Martin GOETZ ; Judith WENDLER ; Nisar P MALEK ; Jan WEHKAMP ; Thomas KLAG

Intestinal Research 2019;17(3):340-348

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO